NCT04237441

Brief Summary

Background: Centralization has improved the outcome of complex operations including cancer surgery. Moreover, the implementation of multidisciplinary team conferences (MDT) has ameliorated the decision making, but the impact on patient outcome is controversial. The aim of the study was to investigate the outcome of pancreatic surgery in the setting of centralization and upfront multidisciplinary decision making.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,294

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 15, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 23, 2020

Completed
Last Updated

November 30, 2023

Status Verified

January 1, 2020

Enrollment Period

7 years

First QC Date

January 15, 2020

Last Update Submit

November 26, 2023

Conditions

Pancreatic Neoplasms

Outcome Measures

Primary Outcomes (2)

  • complications following pancreatic surgery

    study from clinical database

    14 years

  • survival following pancreatic surgery

    study from clinical database

    14 years

Study Arms (2)

MDT conference

participants evaluated at MDT conference

Other: number of participants with surgical complications

no MDT conference

participants not evaluated at MDT conference

Other: number of participants with surgical complications

Interventions

number of participants with surgical complicationsOTHER

observation before and after multidisplinary team conference (MDT) was implemented

Also known as: number of participants surviving months
MDT conferenceno MDT conference

Eligibility Criteria

Age20 Years - 86 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all gender referred to MDT all gender not referred to MDT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • carsten hansen, DMSc

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
chief consultant surgeon

Study Record Dates

First Submitted

January 15, 2020

First Posted

January 23, 2020

Study Start

January 1, 2010

Primary Completion

December 31, 2016

Study Completion

December 31, 2018

Last Updated

November 30, 2023

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share